The Power Of Patient Engagement With CGT Innovation

The story of Emily Whitehead continues to inspire millions. Diagnosed with leukemia at five and given weeks to live, Emily made history by being the first child to undergo CAR-T treatment in 2012. Today, twelve years later, she remains cancer free.

We were delighted to welcome George Eastwood, the Board Chair and Interim Executive Director of the Emily Whitehead Foundation, during Day 2 of The ThinkLive Cell and Gene Therapy Summit 2024, to discuss the critical role of early diagnosis, patient engagement, and support in advancing therapies. From incorporating patient insights to enhance understanding and refining trials through stakeholder collaboration for optimal patient outcomes and fair access, there is still much work needed to improve accessibility.

Watch the full recording for deeper insights into enhancing patient support programs, improving data integration, and prioritizing patient-centric approaches in drug development.